Back to search results

Type 2 Diabetes

A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes (AWARD-PEDS)

GBGC | {{ defaultRegistry.registryAnchorText }} NCT02963766 {{ currentLocaleObject.registryAnchorText }}

Study Purpose

The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics and pharmacodynamics of the study drug dulaglutide compared to placebo in pediatric participants with type 2 diabetes. The study duration is approximately 60 weeks.

Time Commitment

Your participation could last up to 60 weeks and include 8 visits to the study center

Key Participation Requirements Tool Tip Icon

All clinical trials have rules about who can participate. This section outlines some of those rules. Please contact a study center to discuss the full set of criteria


Male Female


10 years
17 years
  • Pediatric participant (child or teen) must have type 2 diabetes, treated with diet and exercise, with or without metformin and/or basal insulin
  • Pediatric participant must be on a stable does of metformin and/or basal insulin for at least 8 weeks
  • Pediatric participant must not have type 1 diabetes
  • Female participant who are having menstrual period must be on birth control if sexually active
  • Pediatric participant must not be taking any medicine for diabetes other than metformin and/or basal insulin and must have stopped any other diabetic medicine at least 3 months prior to starting the first study visit
  • Pediatric participant must not have taken oral steroids within the last 60 days
  • Pediatric participant must not have used prescription weight loss medications in the last 30 days, or plan to use

Where to Participate

Where to Participate

Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location Status
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
{{site.siteStatus | translate}}
Closest Location to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
{{site.siteStatus | translate}}
Other Location(s) to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
{{site.siteStatus | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.